scholarly journals Pulmonary nodules due to reactive systemic amyloidosis (AA) in Crohn's disease.

Thorax ◽  
1993 ◽  
Vol 48 (12) ◽  
pp. 1287-1288 ◽  
Author(s):  
T W Beer ◽  
C W Edwards
2016 ◽  
Vol 10 (2) ◽  
pp. 206-211
Author(s):  
Danyal Thaver ◽  
Mirza Beg

Crohn’s disease (CD) is an autoimmune inflammatory disorder that primarily affects the gastrointestinal tract. It may have pulmonary involvement, which has been rarely reported in pediatric patients. Down syndrome (DS) has been associated with increased frequency of autoimmune diseases. However, associations between CD and DS have been rarely reported. We present the case of a 5-year-old girl with known DS and a history of chronic intermittent abdominal pain who presented with persistent pneumonia. Her workup included a chest computed tomography (CT) scan that showed multiple noncalcified pulmonary nodules. An extensive infectious workup was done that was negative. CT-guided needle biopsy of the lung nodules showed necrotizing granulomas. This raised concern for primary CD with extraintestinal pulmonary manifestation. An esophagogastroduodenoscopy and colonoscopy were performed, and colon biopsies showed scattered epithelioid granulomas. Based on this information, there was consensus that her lung nodules were secondary to CD. She was started on standard therapy for CD, and her abdominal and respiratory symptoms gradually improved. However, she continues to have mild residual lung calcification and fibrosis. To our knowledge, this is the first reported case of pulmonary CD in a child with DS. The natural history of pulmonary CD in the pediatric population is not very well studied. Furthermore, since DS has been well known to be associated with increased frequency of malignancies and autoimmune conditions due to immune dysregulation, it is difficult to predict the severity and possible complications in this patient.


2015 ◽  
Vol 26 (3) ◽  
pp. 279-280
Author(s):  
Mevlut Kurt ◽  
Emrah Posul ◽  
Guray Can ◽  
Bulent Yilmaz ◽  
Ugur Korkmaz ◽  
...  

2011 ◽  
Vol 5 (2) ◽  
pp. 171-172 ◽  
Author(s):  
Yosra Said ◽  
Radhouane Debbeche ◽  
Lamine Hamzaoui ◽  
Mondher Lounissi ◽  
Senda Trabelsi ◽  
...  

1999 ◽  
Vol 117 (4) ◽  
pp. 1031-1032 ◽  
Author(s):  
Ryuichi Iwakiri ◽  
Takanobu Sakemi ◽  
Kazuma Fujimoto

CHEST Journal ◽  
2015 ◽  
Vol 148 (4) ◽  
pp. 656A ◽  
Author(s):  
Kohei Yoshimine ◽  
Kazunori Tobino ◽  
Hiroyuki Miyajima

CHEST Journal ◽  
2009 ◽  
Vol 136 (4) ◽  
pp. 40S
Author(s):  
Bhavinkumar D. Dalal ◽  
Jasdeepa Nagi ◽  
Chirag M. Pandya ◽  
James A. Rowley

2004 ◽  
Vol 18 (11) ◽  
pp. 687-690 ◽  
Author(s):  
Hugh J Freeman ◽  
Jennifer E Davis ◽  
Marcia E Prest ◽  
Edward J Lawson

A 37-year-old man with extensive Crohn's disease of the stomach, small and large intestine for almost a decade developed respiratory symptoms and radiological findings suggestive of pneumonia that failed to resolve with antibiotic treatment. Computed tomography scanning of his lungs showed extensive changes with cavitated parenchymal nodules. Histological evaluation of an open lung biopsy showed granulomatous bronchiolitis and pulmonary necrobiosis. Treatment with steroids and immunosuppression resulted in complete resolution of his clinical symptoms of pneumonia and abnormal computed tomography imaging changes. Granulomatous bronchiolitis and necrobiotic nodules may be a manifestation of Crohn's disease in the absence of microbial agents, including mycobacteria or fungal agents. While a multiplicity of complex pulmonary changes may occur in Crohn's disease, their clinical recognition and precise pathological definition may be particularly important if treatment with a biological agent, such as infliximab, is being considered.


1996 ◽  
Vol 10 (5) ◽  
pp. 297-300 ◽  
Author(s):  
Gad Friedman ◽  
Gary E Wild

Systemic amyloidosis and portal vein thrombosis are relatively rare complications of inflammatory bowel disease. The first case of a patient with Crohn’s disease presenting with both complications is presented. An acquired free protein S deficiency was disclosed in the patient, which may be responsible for the hypercoagulable state observed in Crohn’s disease and the nephrotic syndrome from amyloidosis.


2019 ◽  
Vol 199 (1) ◽  
pp. e1-e2 ◽  
Author(s):  
Lukasz A. Myc ◽  
Mark R. Girton ◽  
Mark H. Stoler ◽  
Eric M. Davis

Sign in / Sign up

Export Citation Format

Share Document